AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 209 filers reported holding AMICUS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,050,000 | -95.1% | 165,000 | -94.2% | 0.01% | -79.2% |
Q1 2018 | $42,079,000 | +1007.6% | 2,825,720 | +965.5% | 0.02% | +242.9% |
Q4 2017 | $3,799,000 | -26.2% | 265,200 | -22.3% | 0.01% | -36.4% |
Q3 2017 | $5,148,000 | +1190.2% | 341,200 | +1108.5% | 0.01% | +1000.0% |
Q2 2015 | $399,000 | +15.7% | 28,233 | -10.6% | 0.00% | 0.0% |
Q1 2015 | $345,000 | +76.0% | 31,565 | +33.6% | 0.00% | 0.0% |
Q4 2014 | $196,000 | +35.2% | 23,631 | -2.9% | 0.00% | – |
Q3 2014 | $145,000 | -68.3% | 24,325 | -82.2% | 0.00% | – |
Q2 2014 | $457,000 | +1887.0% | 136,815 | +1095.2% | 0.00% | – |
Q1 2014 | $23,000 | -73.9% | 11,447 | -69.3% | 0.00% | – |
Q4 2013 | $88,000 | +7.3% | 37,305 | +6.3% | 0.00% | – |
Q3 2013 | $82,000 | -4.7% | 35,093 | -5.6% | 0.00% | -100.0% |
Q2 2013 | $86,000 | – | 37,156 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 21,719,191 | $226,748,000 | 8.80% |
Perceptive Advisors | 27,372,917 | $285,773,000 | 8.29% |
Palo Alto Investors LP | 9,847,774 | $102,811,000 | 8.13% |
Finepoint Capital LP | 1,688,400 | $17,627,000 | 5.80% |
CM Management, LLC | 450,000 | $4,698,000 | 5.24% |
Avoro Capital Advisors LLC | 26,800,000 | $279,792,000 | 5.17% |
Artal Group S.A. | 4,000,000 | $41,760,000 | 1.78% |
Kynam Capital Management, LP | 676,849 | $7,066,000 | 1.49% |
Ghost Tree Capital, LLC | 500,000 | $5,220,000 | 1.46% |
Boxer Capital, LLC | 2,325,000 | $24,273,000 | 1.36% |